INTRODUCTION
A fundamental question in current biomedical research is to establish a link between genomic variation and phenotypic differences, which encompasses both the seemingly neutral polymorphic variation, as well as the pathological variation that causes or predisposes to disease. DNA copy number variants, defined as stretches of DNA larger than 1 kb that display copy number differences in the normal population (1) , have recently gained considerable interest as a source of genetic diversity likely to play a role in functional variation (2 -5) .
Extensive studies were performed to establish CNV catalogs for multiple species, however little is known about the functional impact of CNVs at the cellular and organismal level. Here, we review recent works on the identification of CNVs, their association with disease and their global impact on gene expression, as well as discuss possible mechanisms by which CNVs exert this influence.
COPY NUMBER VARIATION IN HUMAN AND MODEL ORGANISMS
Whole-genome CNV catalogs have been established for the human (4, (6) (7) (8) , the mouse (9) (10) (11) (12) (13) (14) (15) (16) , the rat (17) , the chimpanzee (7, 18) , the rhesus macaque (19) and Drosophila melanogaster (20, 21) (Table 1 ). CNVs were identified by array comparative genome hybridization (aCGH) (22) , either with bacterial artificial chromosome or oligonucleotide probes. Alternatively, bioinformatics mining of whole genome shotgun (WGS) sequences was used to predict CNVs in human, macaque and rat (17, 23, 24) . As observed in humans, distinct array platforms yielded considerably different datasets with little overlap [43% and 37% overlap, respectively (4, 16) ], whereas studies performed using the same platform were shown to be highly reproducible (12, 16) . Similarly, Guryev et al. (17) found a very good correspondence between WGS-based predictions and hybridization methods. On the other hand, changes in calling methods were shown to modify the number of CNV predictions, with methods that congruently analyze aCGH data from multiple samples significantly increasing the number of detectable CNVs (14, 16) .
General characteristics of the CNVs identified in human and model organisms are summarized in Table 1 . Interestingly, the CNVs reported in D. melanogaster are one order of magnitude shorter (maximum 33 kb or 0.017% of the fly genome) than those found in mammals (up to 3 Mb or 0.12% of the mouse genome). A certain synteny has been observed among primates with 22% and 25% of chimpanzee and macaque CNVs overlapping human CNVs (7, 19) . In addition, CNVs identified in multiple macaques were frequently observed in multiple human samples, suggesting the existence of hotspots for CNV (19) . Indeed, structural genomic rearrangements are facilitated by repetitive sequences that provide the substrate for non-allelic homologous recombination (25) . Consistently, CNVs are associated with segmental duplications (SDs) in mammals (2, 4, 7, 8, 11, 12, 19) and to centromeres and telomeres (17, 26) , structures also associated with SDs. For example, as much as 60% of the basepairs mapping inside C57BL/6J SDs were recently shown to be polymorphic among classical mouse inbred strains (14) . In other words, an average of 20 Mb of DNA is variable in number of copies between two laboratory mice in these regions. Similarly, in D. melanogaster, CNVs cluster in regions of the fly genome enriched in tandem repeats, and over half the transposons assessed were demonstrated to vary in number of copies between strains (20) .
On the other hand, the lower boundaries of the ranges of CNV size reflect the resolution of the platforms used, as well as the power and stringency of the prediction algorithms, rather than the actual minimal size of CNVs. A complete cataloguing of CNVs and other structural changes in mammals and other animal models still awaits further analyses with increased resolution and the advent of different approaches that take advantage of high-throughput sequencing (27, 28) . For example, paired-end sequence tag mapping allows the detection of smaller structural variants (down to a few kilobases), however, this approach is biased towards small events, meaning that the different detection techniques should be used in parallel (28, 29) .
Several personal genomes from different ethnicity and of both sexes have been sequenced, each dataset reinforcing the catalog of variants that exist in human genomes (29 -32) . For example, 1.4% of the total sequencing data from the genome of James Watson does not map with the NCBI36 reference assembly, and 23 new CNV regions were identified (32) . Similarly, 2500 and 5000 structural variants were uncovered in an Asian and an African genome, respectively (29, 30) , while Kidd and colleagues (27) found 525 CNV regions in a sample of four African and four non-African genomes. In one Asian male, 34% of the structural variants discovered are novel, and 33 genes were found to be completely or partially disrupted, a change that is homozygous for 30% of these loci. For example, CYP4F12 on chromosome 19 was broken in two segments by an inversion (29) . This epitomizes that the sequencing of large numbers of individuals is needed to fully capture the diversity and complexity of the genome.
The number of polymorphisms of copy numbers identified in the mouse, the only animal model for which we have accumulated a fair amount of data at the moment, appears to be similar, if not greater than that reported in human (14, 16) . However, this type of variation appears to be far more clustered in discrete regions in this model than in humans, probably reflecting the unnatural man-driven establishment of inbred lines. Of note, CNVs and single nucleotide polymorphisms (SNPs) cluster in different regions of the domesticated mouse genome (10, 33) . Consistently, Cutler et al. (10) found that CNV segments were significantly enriched among sequences with low and moderate SNP content. The artificially repeated brother -sister mating of mice over generations has eliminated recessive lethal alleles, but may have increased the fixation of potentially (slightly) deleterious CNV alleles. Consistently, significantly more CNVs were identified in classical inbred strains than in wild-caught Mus musculus domesticus mice (16) .
CNV regions are not only polymorphic within a species, but spontaneous de novo rearrangements can occur even in an inbred population, as shown by recent studies of the classical C57BL/6J strain (13, 16, 34) . Egan et al. and Henrichsen et al. identified and validated 38 and 39 CNVs in this isogenic strain, respectively, 18 of which occurred through recurrent mutations (13, 16) . In addition, a single-copy and a duplication allele of the CNV spanning the Ide locus were found to be in Hardy -Weinberg equilibrium 14 years after their appearance in the Jackson Laboratory colony (34) . These findings illustrate the highly dynamic nature of CNV regions and challenge the notion of the isogenicity of inbred strains (35) . shown to be associated with both mental retardation and schizophrenia. A more detailed investigation of cases might shed light on a possible link between these conditions. Interestingly, while deletions at all three loci were linked to schizophrenia and related psychoses (50, 51) , the maternal duplication of the entire 15q11-q13 region was shown to cause autism spectrum disorder (ASD) (66) . Similarly, duplication of band 1q21.1 was identified in patients with ASD, whereas both deletions and duplications were associated with mental retardation. These examples suggest that some conditions might not be associated with a specific number of copies of a particular CNV, but rather that the simple presence of a structural change at a given position of the human genome may cause perturbation in particular pathways regardless of gene dosage. CNV has also been shown to induce phenotypes in nonmammalian vertebrates and in invertebrates. For example, copy number amplification of regions containing the mannosebinding lectin and the pfmdr1 and gch1 genes influence the zebrafish susceptibility to bacterial infection and malaria parasite Plasmodium falciparum drug resistance, respectively (67, 68) .
FROM GENOTYPE TO PHENOTYPE-BRIDGING THE GAP
Phenotypic effects of genetic differences, both at the singlenucleotide and large-scale level, are supposedly brought about by changes in expression levels, either directly affecting the genes concerned by the genetic change, or indirectly through position effects or downstream pathways and regulatory networks (69, 70) . Thus, transcriptome analyses and singlegene expression studies seem appropriate proxies to study the consequences of CNV.
A first attempt to estimate the contribution of CNVs to gene expression variation found that in human lymphoblastoid cell lines, changes in copy numbers capture about one-fifth of the detected genetic variation (71) . This type of approach, however, does not allow to follow the influence of CNVs in multiple tissues nor developmental stages, as an individual will have been the source of a limited number of cell lines, typically a skin fibroblast and a lymphoblastoid cell line or, more rarely, different cell lines from umbilical cord. This difficulty can be overcome using animal models, as recent analyses suggest that CNVs are also important contributors to their phenotypic variation (Table 1 ). In some cases given CNVs were shown to cause the same phenotype in a model organism and in human patients, further exemplifying the validity of models studies. For example, Aitman et al. (40) showed that lower copy number of the Fcgr3 gene predisposed both rats and humans to immunologically mediated glomerulonephritis. In addition to natural CNV, structural modifications can be engineered into model organisms, e.g. mice, and thus allow the study of different alleles of a CNV, as well as position effects, in a genetically homogenous background (72, 73) .
Two recent reports attempted to assess the effects of CNVs on tissue transcriptomes of rats and mice (16, 17) . Both studies report an over-representation of differentially expressed genes among CNV-mapping transcripts. Globally, a weak yet significant positive correlation was found between relative expression level and gene dosage (see examples in Fig. 1 ). This correlation was driven by a restricted number of genes, as only a fraction of genes comprised between 5% and 18% in function of the tissue and the rodent species analyzed showed a strong correlation between number of copies and relative expression levels (16,17) (see example in Fig. 1A and possible mechanism in Fig. 2B ). In about two-third of the genes, however, the number of copies had no effect on relative expression levels in any tissue (see example in Fig. 1C ), suggesting either dosage compensation mechanisms or the incomplete inclusion of regulatory elements in the deletion/duplication event (see possible mechanisms in Fig. 2 ). In addition, genetic imprinting may also modulate the expression at a CNV locus, in a parental allele-dependent manner (74) . The first hypothesis is supported by the observation that expression of some genes correlated with gene dosage in some tissues but not in others (see examples in Fig. 1D and mechanisms in Fig. 2B and C) , whereas the second is supported by studies of the quantitative collinearity of Hoxd genes, which showed that their expression levels are correlated with their rank in the Hoxd cluster (75) (see mechanism in Fig. 2D) . Alternatively, the multiple copies of a gene might be mapping to different chromatin environments and thus be regulated differentially (Fig. 2E) ; indeed, aCGH does not allow discriminating tandem from non-tandem duplications. Furthermore, for 2 -15% of the genes depending on the tissue and the rodent assessed, the recorded relative expression levels were significantly inversely correlated with CNV (16,17) (see examples in Fig. 1B) . The mechanism of this effect is still poorly understood, but may be explained by two models summarized in Fig. 2F and 2G . In the first model, a negative correlation between number of copies and relative expression is explained by immediate early genes (IEG, Fig. 2F ). These genes are initially expressed at levels proportional to their number of copies ( Fig. 2A and B) . These IEG induce directly or indirectly the expression of a repressor which, by a negative feedback loop, reduces or even abolishes the expression of the CNV gene (Fig. 2F ).
In the second hypothesis, the extra copies of a gene impair through steric hinderance their access to a specific transcription factory, where this particular locus should be transcribed (76) (Fig. 2G) .
Genes mapping to CNVs show lower expression levels than transcripts that do not vary in numbers of copies, both in fly and mouse (16, 20) . These observations suggest that CNV genes might be more specific in their expression patterns than other genes. In support of this notion, CNV genes were detectable in a smaller number of tissues than non-CNV genes both in the mouse and Drosophila (16, 20) . In addition, Dopman and Hartl (20) observed that the CNV genes expressed in the fly midgut and male accessory glands were enriched for functions relevant to these tissues, defense response in both cases and post-mating behavior genes in the latter case.
Large-scale rearrangements do not only affect expression by altering gene dosage. The deletion associated with WilliamsBeuren syndrome was shown to modify the expression of some of the normal-copy number neighboring genes in human lymphoblastoid and skin fibroblast cell lines (77) . Consistently, Stranger et al. (71) observed that although CNVs capture 18% of the detected genetic variation in lymphoblastoid cell lines, more than half of the identified associations between copy numbers and expression levels involved genes mapping outside the CNV intervals. Likewise, an engineered duplication of a segment of mouse chromosome 11, that models the rearrangement present in Potocki-Lupski syndrome patients, was shown to affect the expression of both the genes mapping within the duplicated interval and its flanks (72) . Thus, CNVs also profoundly affect the expression of genes located in their vicinity. This effect extends over half a megabase into their genomic neighborhoods (16, 17) . But how may changes in copy number of CNV regions alter the expression of genes in their vicinity? Different CNV-induced mechanisms that include the physical dissociation of the transcription unit from its cis-acting regulators (78, 79) , modification of transcriptional control through alteration of chromatin structure (80 -83) and modification of the positioning of chromatin within the nucleus and/or within a chromosome territory of a genomic region (84,85) might play a role, both individually or in combination. Copy number changes might also influence gene expression through perturbation of transcript structure (70, 86, 87) . Similar mechanisms might explain how some pathways are perturbed without correlation with a particular number of copies of a CNV (see above). Detailed investigations of the different mechanisms by which CNVs influence gene expression are warranted to shed light on how CNVs alter the architecture of chromosomal segments and thus influence the expression of genes.
CONCLUSION
The identification of CNVs in both human and model organisms and their association with diseases and phenotypes have confirmed that these genome structural changes are important contributors to variation. They exert their influence by modifying the expression of genes mapping within and close to the rearranged region.
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